Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ETR/5CV stock hub

ETR/5CV has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/5CVis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

n/a

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/5CV

In the news

Latest news · ETR/5CV

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 15.7P75 20.2

Trailing P/En/a

P25 16.4P50 20.9P75 30.4

ROEn/a

P25 -6.7P50 8.5P75 17.2

ROIC41.4

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/5CV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

165

Groups with data

Currency

EUR

Showing 165 of 165 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Netherlands
Country code	DE
Employees	904
Employees Change	-189%
Employees Change Percent	-16.13
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	NL0015436031
Last refreshed	2026-05-10
Price	EUR 3.91
Price currency	EUR
Rev Per Employee	78,253.32x
Sector	Healthcare
Sic	2836
Symbol	etr/5CV

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	257.38%
EBITDA Margin	273.81%
Gross margin	93.29%
Gross Profit	EUR 66M
Gross Profit Growth	-83.23%
Gross Profit Growth Q	-88.61%
Gross Profit Growth5 Y	14.42%
Net Income	EUR 128.8M
Net Income Growth	18.96%
Net Income Growth Q	-19.17%
Net Income Growth Years	1%
Pretax Margin	222.5%
Profit Margin	182.11%
Profit Per Employee	EUR 142,504
Profitable Years	1
Roa5y	-15.2
ROCE	20.18
Roe5y	-32.21
ROIC	41.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	13.29%
Cagr3y	-13.74%
Cagr5y	-43.7%
EPS Growth	94.02
EPS Growth Q	23.97
EPS Growth Years	3
FCF Growth Q	-91.56%
OCF Growth Q	-91.57%
Revenue Growth	-86.98x
Revenue Growth Q	-89.04x
Revenue Growth Years	1x
Revenue Growth3 Y	-9.97x
Revenue Growth5 Y	7.34x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 1.1B
Cash	EUR 416.1M
Current Assets	EUR 873.1M
Current Liabilities	EUR 236.2M
Debt	EUR 35.1M
Debt EBITDA	EUR 0.18
Debt Equity	EUR 0.04
Debt FCF	EUR -0.28
Equity	EUR 871.2M
Interest Coverage	29.46
Liabilities	EUR 267.4M
Long Term Assets	EUR 265.5M
Long Term Liabilities	EUR 31.2M
Net Cash	EUR 381M
Net Debt EBITDA	EUR -1.97
Net Debt Equity	EUR -0.44
Tangible Book Value	EUR 846.6M
Tangible Book Value Per Share	EUR 4.68

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.7
Net Working Capital	EUR 225.6M
Quick ratio	1.88
Working Capital	EUR 636.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	38.7%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	13.28%
200-day SMA	4.14
3Y total return	-35.82%
50-day SMA	4.35
50-day SMA vs 200-day SMA	50over200
5Y total return	-94.34%
All Time High	120.8
All Time High Change	-96.77%
All Time High Date	2020-12-09
All Time Low	2
All Time Low Change	95.3%
All Time Low Date	2025-04-07
ATR	0.17
Beta	1.87
Ch YTD	7.9
High	3.96
High52	4.9
High52 Date	2025-06-12
High52ch	-20.29%
Low	3.86
Low52	2
Low52 Date	2025-04-07
Low52ch	95.3%
Ma50ch	-10.29%
Price vs 200-day SMA	-5.7%
RSI	43.6
RSI Monthly	41.93
RSI Weekly	41.84
Sharpe ratio	0.17x
Sortino ratio	0.43
Total Return	38.7%
Tr YTD	7.9
Tr1m	-11.43%
Tr1w	8.02%
Tr3m	-15.31%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 182.1M
Operating Income Growth	25.88
Operating Income Growth Q	-15.79
Operating margin	257.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	-5,249,000
Shares Qo Q	-21.6%
Shares Yo Y	-38.7%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -129.6M
Average Volume	427,092.45x
Bv Per Share	4.81
CAPEX	EUR -4M
Ch1m	-11.43
Ch1w	8.02
Ch1y	13.28
Ch3m	-15.31
Ch3y	-35.82
Ch5y	-94.34
Ch6m	-14.79
Change	0.72%
Change From Open	0.26
Close	3.88
Days Gap	0.46
Depreciation Amortization	11,618,000
Dollar Volume	489,312.4
Earnings Date	2026-04-24
EBIT	EUR 182.1M
EBITDA	EUR 193.7M
EPS	EUR 0.8
F Score	2
FCF	EUR -124.1M
Financing CF	-5,189,000
Fiscal Year End	December
Founded	2,000
Graham Number	9.29886
Graham Upside	138.1
Income Tax	EUR 28.6M
Investing CF	-4,958,000
Is Primary Listing	0
Last Earnings Date	2025-11-12
Last Report Date	2025-09-30
Ma150	4.51
Ma150ch	-13.35%
Ma20	4.02
Ma20ch	-2.81%
Net CF	-134,772,000
Open	3.9
Position In Range	44.9
Ppne	235,603,000
Price Date	2026-01-05
Relative Volume	0.29x
Revenue	70,741,000x
SBC By Revenue	7.72x
Share Based Comp	5,462,000
Tax By Revenue	40.39x
Tax Rate	18.15%
Tr6m	-14.79%
Volume	125,272
Z Score	1.52

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ETR/5CV pay a dividend?

Capital-return profile for this ticker.

Performance

ETR/5CV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/5CV?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-38.7%

Negative means the company is buying back shares.

Technical

ETR/5CV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.6

Neutral momentum band

Price vs 200-day MA

-5.7%

50/200-day relationship not available

Beta (5Y)

1.87

More volatile than the market

Sharpe ratio

0.17

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/5CV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/5CV stock rating?

etr/5CV is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/5CV analysis?

The full report lives at /stocks/etr/5CV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/5CV?

The latest report frames etr/5CV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/5CV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.